IDEAYA Biosciences Earnings
NASDAQ: IDYAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.28
IDEAYA Biosciences earnings summary
IDEAYA Biosciences is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $-1.28. In its most recent report on Aug 4, 2026 (Q2 2026), IDYA posted EPS of $-1.22. Revenue for the quarter was $8.9 million.
Across the last 16 reports, IDYA shares moved an average of 3.4% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
IDYA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $-1.22 | — | -1.9% |
| May 5, 2026 | — | $-1.11 | — | -0.4% |
| Feb 17, 2026 | — | $-0.91 | — | +0.7% |
| Nov 4, 2025 | — | $1.33 | — | +6.3% |
| Aug 5, 2025 | — | $-0.88 | — | +5.3% |
| May 6, 2025 | — | $-0.82 | — | +2.3% |
| Feb 18, 2025 | — | $-1.55 | — | -5.9% |
| Nov 4, 2024 | — | $-0.60 | — | -14.8% |
| Aug 6, 2024 | — | $-0.68 | — | -0.3% |
| May 7, 2024 | — | $-0.53 | — | -1.6% |
| Feb 20, 2024 | — | $-0.51 | — | +0.7% |
| Nov 7, 2023 | — | $-0.46 | — | +3.3% |
| Aug 10, 2023 | — | $-0.50 | — | +4.8% |
| May 9, 2023 | — | $-0.49 | — | +1.7% |
| Mar 7, 2023 | — | $-0.53 | — | -2.6% |
| Nov 8, 2022 | — | $0.04 | — | +2.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.